Note 4 — Supplemental Financial Information (in thousands):


	February 2, 2013		January 28, 2012
Cash and cash equivalents
Cash	$	583,527	$	503,095
Cash equivalents:
Corporate debt securities		—		12,500
Time deposits		119,874		205,060
Money market mutual fund		21,523		64,247
U.S. federal and state debt securities		27,029		—

Total cash and cash equivalents	$	751,953	$	784,902


	February 2, 2013		January 28, 2012
Inventories:
Work-in-process	$	140,805	$	190,779
Finished goods		109,615		163,340

Inventories	$	250,420	$	354,119


	February 3, 2013			January 28, 2012
Property and equipment, net:
Machinery and equipment	$	532,420		$	489,481
Buildings		144,320			144,320
Computer software		89,548			81,852
Land		69,246			69,246
Building improvements		49,516			42,083
Leasehold improvements		46,205			37,237
Furniture and fixtures		25,301			24,726
Construction in progress		5,333			9,846

		961,889			898,791
Less: Accumulated depreciation and amortization		(574,862	)		(514,990	)

Property and equipment, net	$	387,027		$	383,801

The Company recorded depreciation expense of $70.7 million, $63.5 million and $72.2 million for fiscal 2013, 2012 and 2011, respectively.


	February 2, 2013		January 28, 2012
Other non-current assets:
Technology and other licenses	$	81,523	$	50,212
Deferred tax assets		26,291		31,064
Deposits		10,451		11,532
Investments in privately held companies		14,486		6,309
Deferred compensation		3,220		5,419
Other		14,858		3,610

Other non-current assets	$	150,829	$	108,146

Amortization of technology and other licenses was $20.3 million, $24.9 million, and $21.0 million in fiscal 2013, 2012 and 2011, respectively.


	February 2, 2013		January 28, 2012
Accrued liabilities:
Accrued rebates	$	51,712	$	24,420
Accrued share repurchases		22,152		—
Accrued legal expense		18,357		13,999
Accrued royalties		12,695		16,896
Technology license obligations		9,865		5,250
Other		29,210		27,090

Accrued liabilities	$	143,991	$	87,655

In connection with the Company’s repurchases of its common shares during fiscal 2013, approximately $22.2 million of the repurchases was made in the final 3 days of the fiscal year and is included in accrued share repurchases in the consolidated balance sheet. The repurchased shares were retired immediately after the repurchases were completed.


	February 2, 2013		January 28, 2012
Other non-current liabilities:
Technology license obligations	$	34,270	$	—
Long-term accrued employee compensation		6,205		10,059
Other		15,935		22,409

Other non-current liabilities	$	56,410	$	32,468


	February 2, 2013			January 28, 2012
Accumulated other comprehensive income:
Unrealized gain on marketable securities	$	2,742		$	3,702
Unrealized loss on auction rate securities		(2,681	)		(1,285	)
Unrealized gain (loss) on cash flow hedges		1,087			(1,641	)

Accumulated other comprehensive income	$	1,148		$	776

Net income per share

The Company reports both basic net income per share, which is based on the weighted average number of common shares outstanding, and diluted net income per share, which is based on the weighted average number of common shares outstanding and potentially dilutive common shares. The computations of basic and diluted net income per share are presented in the following table (in thousands, except per share amounts):


	Year Ended
	February 2, 2013		January 28, 2012		January 29, 2011
Numerator:
Net income:	$	306,585	$	615,091	$	904,129

Denominator:
Weighted average common shares outstanding:		555,310		607,857		648,347
Effect of dilutive securities:
Common share-based awards		7,813		15,411		28,531

Weighted average shares — diluted		563,123		623,268		676,878

Net income per share:
Basic	$	0.55	$	1.01	$	1.39
Diluted	$	0.54	$	0.99	$	1.34


	Year Ended
	February 2, 2013		January 28, 2012		January 29, 2011
Anti-dilutive potential common shares:
Weighted average shares outstanding from stock options		28,124		21,014		12,211

Weighted-average exercise price:	$	17.48	$	18.79	$	21.39

Anti-dilutive potential common shares for stock options are excluded from the calculation of diluted earnings per share for the periods reported above because their exercise price exceeded the average market price during the period. The anti-dilutive shares reported above also include shares from stock options that contain market conditions for vesting since the market value of the Company’s stock as of February 2, 2013, January 28, 2012 and January 29, 2011 was lower than the required market condition. There were 3.0 million anti-dilutive shares in each of fiscal 2013 and 2012 and 3.1 million anti-dilutive shares in fiscal 2011, from stock options that contain market conditions. See “Note 12 — Shareholders’ Equity” for additional details.